Sign in

CIK 0001907108 · <br>Emerging growth company

Lexeo Therapeutics, Inc.

Sign in to watch
Ticker
LXEO
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Entity type
operating
EIN
854012572
Phone
(212) 547-9879
Business address
345 PARK AVENUE SOUTH, FLOOR 6, NEW YORK, NY, 10010
  1. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  2. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  3. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  4. 10-Q Report Quarterly Report
  5. 8-K Event Results of operations
  6. ARS Other Annual Report to Security Holders
  7. DEFA14A Proxy Proxy Materials
  8. DEF 14A Proxy Proxy Statement
  9. SCHEDULE 13G Stake Statement of Beneficial Ownership
  10. 4 Insider Changes in Ownership
  11. 4 Insider Changes in Ownership
  12. 4 Insider Changes in Ownership
  13. 8-K Event Regulation FD disclosure · Other events
  14. 4 Insider Changes in Ownership
  15. S-8 POS Other Post-effective Amendment
  16. 424B5 Offering Prospectus
  17. S-8 Other Securities Offered to Employees in Benefit Plans
  18. 10-K Report Annual Report
  19. 8-K Event Results of operations
  20. 4 Insider Changes in Ownership

Page 10 of 19 · 362 filings